NYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidose — 2 flacons pulvérisateurs nasaux en récipient unidose de 0,1 mL
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930181393 -
CIP7
3018139 -
CIS
63868145 -
Registration number
EU/1/17/1238
What the source publishes
- Holder
- MUNDIPHARMA CORPORATION (IRELAND)
- Active ingredients
- NALOXONE, CHLORHYDRATE DE NALOXONE DIHYDRATÉ
- Form
- solution pour pulvérisation
- Package
- 2 flacons pulvérisateurs nasaux en récipient unidose de 0,1 mL
- Routes
- nasale
- Administrative status
- authorised
- Supply regime
- médicament soumis à prescription médicale
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2017-11-10
- Prescription
- Prescription or restricted
Names this record is found by
- NYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidose — 2 flacons pulvérisateurs nasaux en récipient unidose de 0,1 mL
- NYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidose
- NALOXONE
- CHLORHYDRATE DE NALOXONE DIHYDRATÉ
Complete source data
{
"cis": "63868145",
"cip7": "3018139",
"form": "solution pour pulvérisation",
"name": "NYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidose — 2 flacons pulvérisateurs nasaux en récipient unidose de 0,1 mL",
"cip13": "3400930181393",
"holder": "MUNDIPHARMA CORPORATION (IRELAND)",
"routes": [
"nasale"
],
"holders": [
"MUNDIPHARMA CORPORATION (IRELAND)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "32.42",
"authorisedOn": "2017-11-10",
"compositions": [
{
"name": "NALOXONE",
"nature": "FT",
"strength": "1,8 mg",
"linkageNumber": "1",
"substanceCode": "65807",
"dosageReference": "une dose",
"pharmaceuticalElement": "solution"
},
{
"name": "CHLORHYDRATE DE NALOXONE DIHYDRATÉ",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "79853",
"dosageReference": null,
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament soumis à prescription médicale",
"dispensingFee": "1.02",
"medicinePrice": "31.40",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "NYXOID 1,8 mg, solution pour pulvérisation nasale en récipient unidose",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "2 flacons pulvérisateurs nasaux en récipient unidose de 0,1 mL",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2021-09-20",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"NALOXONE",
"CHLORHYDRATE DE NALOXONE DIHYDRATÉ"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"médicament soumis à prescription médicale"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/17/1238",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930181393"